The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials
Open accessAbstract
Background: Many patients with borderline personality disorder receive pharmacological treatment, but there is uncertainty about the usefulness of such therapies. Aims: To evaluate the evidence of effectiveness of pharmacotherapy in treating different facets of the psychopathology of borderline personality disorder. Method: A Cochrane Collaboration systematic review and meta-analysis of randomised comparisons of drug v. placebo, drug v. drug, or single drug v. combined drug treatment in adult patients with borderline personality disorder was conducted. Primary outcomes were overall disorder severity as well as specific core symptoms. Secondary outcomes comprised associated psychiatric pathology and drug tolerability. Results: Twenty-seven trials were included in which first- and second-generation antipsychotics, mood stabilisers, antidepressants and omega-3 fatty acids were tested. Most beneficial effects were found for the mood stabilisers topiramate, lamotrigine and valproate semisodium, and the second-generation antipsychotics aripiprazole and olanzapine. However, the robustness of findings is low, since they are based mostly on single, small studies. Selective serotonin reuptake inhibitors so far lack high-level evidence of effectiveness. Conclusions: The current evidence from randomised controlled trials suggests that drug treatment, especially with mood stabilisers and second-generation antipsychotics, may be effective for treating a number of core symptoms and associated psychopathology, but the evidence does not currently support effectiveness for overall severity of borderline personality disorder. Pharmacotherapy should therefore be targeted at specific symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Assessing Risk of Bias in Included Studies
Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch8 · Cited by 3,396
Chan, A.-W., Hróbjartsson, A., Haahr, M. T., Gøtzsche, P. C., & Altman, D. G. (2004) · JAMA · doi:10.1001/jama.291.20.2457 · Cited by 1,845
Analysing Data and Undertaking Meta‐Analyses
Deeks, J. J., Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch9 · Cited by 1,800
Grant, B. F., Chou, S. P., Goldstein, R. B., Huang, B., Stinson, F. S., Saha, T. D., Smith, S. M., Dawson, D. S., Pulay, A. J., Pickering, R. P., et al. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0404 · Cited by 1,618
Borderline personality disorder
Lieb, K., Zanarini, M. C., Schmahl, C., Linehan, M. M., & Bohus, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16770-6 · Cited by 1,369
Self-citationThe Prevalence of Personality Disorders in a Community Sample
Torgersen, S., Kringlen, E., & Cramer, V. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.6.590 · Cited by 1,313
Cited by
Goodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, Jr., Grunze, H., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116636545 · Cited by 1,309
Psychological therapies for people with borderline personality disorder.
Stoffers-Winterling, J. M., Völlm, B. A., Rücker, G., Timmer, A., Huband, N., & Lieb, K. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005652.pub2 · Cited by 895
Self-citationBorderline personality disorder
Leichsenring, F., Leibing, E., Kruse, J., New, A. S., & Leweke, F. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61422-5 · Cited by 895
Davies, E. B., Morriss, R., & Glazebrook, C. (2014) · Journal of Medical Internet Research · doi:10.2196/jmir.3142 · Cited by 499
Borderline personality disorder
Gunderson, J. G., Herpertz, S. C., Skodol, A. E., Torgersen, S., & Zanarini, M. C. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.29 · Cited by 470
Treatment of personality disorder
Bateman, A. W., Gunderson, J., & Mulder, R. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61394-5 · Cited by 349
Schulze, L., Schmahl, C., & Niedtfeld, I. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.03.027 · Cited by 345
Borderline personality disorder
Bohus, M., Stoffers-Winterling, J., Sharp, C., Krause-Utz, A., Schmahl, C., & Lieb, K. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00476-1 · Cited by 306
Self-citationPharmacological interventions for borderline personality disorder
Stoffers, J., Völlm, B. A., Rücker, G., Timmer, A., Huband, N., & Lieb, K. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005653.pub2 · Cited by 302
Self-citationSempértegui, G. A., Karreman, A., Arntz, A., & Bekker, M. H. J. (2013) · Clinical Psychology Review · doi:10.1016/j.cpr.2012.11.006 · Cited by 177
Carter, G., Page, A., Large, M., Hetrick, S., Milner, A. J., Bendit, N., Walton, C., Draper, B., Hazell, P., Fortune, S., et al. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416661039 · Cited by 167
“, 2013) and pharmacological treatments (Bellino et al., 2011; Duggan et al., 2008; Ingenhoven et al., 2010; Lieb et al., 2010; Mercer et al., 2009; Stoffers et al., 2009).”
BackgroundMethodOud, M., Arntz, A., Hermens, M. L., Verhoef, R., & Kendall, T. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867418791257 · Cited by 134
Complex Trauma in Adolescents and Adults
Briere, J., & Scott, C. (2015) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2015.05.004 · Cited by 114
Evidence-based pharmacotherapy for personality disorders
Ripoll, L. H., Triebwasser, J., & Siever, L. J. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000071 · Cited by 83
Zeifman, R. J., & Wagner, A. C. (2020) · Journal of Contextual Behavioral Science · doi:10.1016/j.jcbs.2019.11.001 · Cited by 67
Depression in Patients with Borderline Personality Disorder
Yoshimatsu, K., & Palmer, B. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000045 · Cited by 57
Buerger, A., Fischer-Waldschmidt, G., Hammerle, F., Auer, K. V., Parzer, P., & Kaess, M. (2019) · Journal of Personality Disorders · doi:10.1521/pedi_2018_32_334 · Cited by 46
Slotema, C. W., Blom, J. D., Niemantsverdriet, M. B. A., Deen, M., & Sommer, I. E. C. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00084 · Cited by 46
Rosenbluth, M., MacQueen, G., McIntyre, R. S., Beaulieu, S., & Schaffer, A. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400106 · Cited by 12
Zimmerman, M., Balling, C., Chelminski, I., & Dalrymple, K. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.09.012 · Cited by 10
Ellappan, S., Subba, R., & Mondal, A. C. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111403 · Cited by 4
Metadata
- Authors
- Lieb, K., Völlm, B., Rücker, G., Timmer, A., & Stoffers, J. M.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2010-01
- Volume
- 196
- Issue
- 1
- Pages
- 4-12
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2145076401
- Cited by
- 410
- References
- 53
- FWCI
- 3.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.